vimarsana.com
Home
Live Updates
Emergent BioSolutions Stock Rises 17% on FDA Narcan Approval
Emergent BioSolutions Stock Rises 17% on FDA Narcan Approval
Emergent BioSolutions Stock Rises 17% on FDA Narcan Approval
By Will Feuer
Shares of Emergent BioSolutions Inc. rose after the U.S. Food and Drug Administration said the company's overdose reversal medication Narcan could be sold over-the-counter for... | March 29, 2023
Related Keywords
Robert Califf ,
Emergent Biosolutions Inc ,
Drug Administration ,
Will Feuer ,
Emergent Biosolutions ,
Dow Jones ,
Emergent Biosolutions Inc Stock Exchange ,
News ,
Information ,
Press Release ,
Y ,
Hill ,
Euer ,
Hares ,
F ,
Emergent ,
Ibiosolutions ,
Nose ,
After ,
The ,
Wood ,
End ,
Drug ,
Administration ,
Aid ,
Overdose ,
Reversal ,
Medication ,
Narcan ,
Would ,
He ,
Old Ebs Us29089q1058 ,